Literature DB >> 28378641

Downregulation of PRDM1 promotes cellular invasion and lung cancer metastasis.

Zhiyan Zhu1,2, Hao Wang1, Yiliang Wei1, Fanrong Meng1, Zhe Liu1, Zhenfa Zhang3.   

Abstract

The zinc-finger transcription factor PRDM1 (PR domain containing 1) plays key roles in the development of malignant lymphoma, leukaemia and some non-haematopoietic cancers, including breast cancer, colorectal cancer and glioma. However, little is known regarding the function of PRDM1 in the progression of lung cancer. Here, we found that PRDM1 is expressed in normal human lung epithelium but is downregulated in lung cancer cells. Decreased expression of PRDM1 correlates with poor prognosis in lung cancer. Depletion of PRDM1 in lung cancer cells promotes cellular invasion and anoikis resistance in vitro and lung metastasis in vivo. PRDM1 is silenced by an ectopically expressed lymphocyte-specific transcription factor Aiolos. The transcription of these two genes is negatively correlated in 206 lung epithelial cell lines. Our results indicate that PRDM1 functions as a tumour suppressor in lung cancer.

Entities:  

Keywords:  PRDM1; gene silencing; lung cancer; metastasis; transcriptional regulation

Mesh:

Substances:

Year:  2017        PMID: 28378641     DOI: 10.1177/1010428317695929

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  14 in total

Review 1.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

Review 2.  Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.

Authors:  Yuan Cheng; Cai He; Manni Wang; Xuelei Ma; Fei Mo; Shengyong Yang; Junhong Han; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2019-12-17

3.  Loss of prdm1a accelerates melanoma onset and progression.

Authors:  Ritsuko Iwanaga; Brittany T Truong; Jessica Y Hsu; Karoline A Lambert; Rajesh Vyas; David Orlicky; Yiqun G Shellman; Aik-Choon Tan; Craig Ceol; Kristin Bruk Artinger
Journal:  Mol Carcinog       Date:  2020-06-20       Impact factor: 4.784

4.  Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population.

Authors:  Katarzyna Białkowska; Wojciech Marciniak; Magdalena Muszyńska; Piotr Baszuk; Satish Gupta; Katarzyna Jaworska-Bieniek; Grzegorz Sukiennicki; Katarzyna Durda; Tomasz Gromowski; Marcin Lener; Karolina Prajzendanc; Alicja Łukomska; Cezary Cybulski; Tomasz Huzarski; Jacek Gronwald; Tadeusz Dębniak; Jan Lubiński; Anna Jakubowska
Journal:  Hered Cancer Clin Pract       Date:  2020-07-31       Impact factor: 2.857

5.  Epigenome-wide scan identifies differentially methylated regions for lung cancer using pre-diagnostic peripheral blood.

Authors:  Naisi Zhao; Mengyuan Ruan; Devin C Koestler; Jiayun Lu; Carmen J Marsit; Karl T Kelsey; Elizabeth A Platz; Dominique S Michaud
Journal:  Epigenetics       Date:  2021-05-19       Impact factor: 4.528

6.  KPNA2 interaction with CBX8 contributes to the development and progression of bladder cancer by mediating the PRDM1/c-FOS pathway.

Authors:  Fanchang Zeng; Liumei Luo; Daoyuan Li; Juncheng Guo; Min Guo
Journal:  J Transl Med       Date:  2021-03-17       Impact factor: 5.531

Review 7.  Emerging Roles of PRDM Factors in Stem Cells and Neuronal System: Cofactor Dependent Regulation of PRDM3/16 and FOG1/2 (Novel PRDM Factors).

Authors:  Paweł Leszczyński; Magdalena Śmiech; Emil Parvanov; Chisato Watanabe; Ken-Ichi Mizutani; Hiroaki Taniguchi
Journal:  Cells       Date:  2020-12-04       Impact factor: 6.600

Review 8.  Multifaceted Role of PRDM Proteins in Human Cancer.

Authors:  Amelia Casamassimi; Monica Rienzo; Erika Di Zazzo; Anna Sorrentino; Donatella Fiore; Maria Chiara Proto; Bruno Moncharmont; Patrizia Gazzerro; Maurizio Bifulco; Ciro Abbondanza
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

9.  Differential epigenetic regulation between the alternative promoters, PRDM1α and PRDM1β, of the tumour suppressor gene PRDM1 in human multiple myeloma cells.

Authors:  Raquel Romero-García; Laura Gómez-Jaramillo; Rosa María Mateos; Gema Jiménez-Gómez; Nuria Pedreño-Horrillo; Esther Foncubierta; Juan Francisco Rodríguez-Gutiérrez; Sebastián Garzón; Francisco Mora-López; Carmen Rodríguez; Luis M Valor; Antonio Campos-Caro
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

10.  Transcription factor NF-κB promotes acute lung injury via microRNA-99b-mediated PRDM1 down-regulation.

Authors:  Jie Zhao; Fei Xie; Ruidong Chen; Zhen Zhang; Rujun Dai; Na Zhao; Rongxin Wang; Yanhong Sun; Yue Chen
Journal:  J Biol Chem       Date:  2020-10-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.